These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36881267)

  • 41. Preventive effect of reduced glutathione on contrast-induced nephropathy in elderly patients undergoing coronary angiography or intervention: a randomized, controlled trial.
    Jin B; Wu BW; Zhang JJ; Luo XP; Shi HM
    Braz J Med Biol Res; 2015 Sep; 48(9):839-42. PubMed ID: 26176313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.
    Wang Y; Zhao HW; Zhang XJ; Chen BJ; Yu GN; Hou AJ; Luan B
    BMC Cardiovasc Disord; 2019 Mar; 19(1):74. PubMed ID: 30922230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the usefulness of gadodiamide and iodine mixture versus iodinated contrast alone for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography.
    Reed PS; Dixon SR; Boura JA; O'Neill WW; Kahn JK
    Am J Cardiol; 2007 Oct; 100(7):1090-3. PubMed ID: 17884368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic accuracy of serum cystatin C for early recognition of contrast induced nephropathy in Western Indians undergoing cardiac catheterization.
    Shukla AN; Juneja M; Patel H; Shah KH; Konat A; Thakkar BM; Madan T; Prajapati J
    Indian Heart J; 2017; 69(3):311-315. PubMed ID: 28648419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients.
    Osugi N; Suzuki S; Shibata Y; Tatami Y; Harata S; Ota T; Hayashi M; Yasuda Y; Ishii H; Shimizu A; Murohara T
    Clin Exp Nephrol; 2017 Jun; 21(3):391-397. PubMed ID: 27339445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lower blood vitamin D levels are associated with an increased incidence of contrast-induced nephropathy in patients undergoing coronary angiography.
    Sahin I; Gungor B; Can MM; Avci II; Guler GB; Okuyan E; Biter H; Yildiz SS; Ayca B; Satilmis S; Dinckal MH
    Can J Cardiol; 2014 Apr; 30(4):428-33. PubMed ID: 24680172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ascorbic Acid for the prevention of contrast-induced nephropathy after coronary angiography in patients with chronic renal impairment: a randomized controlled trial.
    Dvoršak B; Kanič V; Ekart R; Bevc S; Hojs R
    Ther Apher Dial; 2013 Aug; 17(4):384-90. PubMed ID: 23931876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial.
    Liu Y; Chen JY; Huo Y; Ge JB; Xian Y; Duan CY; Chen SQ; Jiang W; Chen PY; Tan N;
    Am Heart J; 2016 Feb; 172():88-95. PubMed ID: 26856220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.
    Chanin JM; Yang DC; Haider MA; Swaminathan RV; Kim LK; Charitakis K; Tanoue M; Minutello RM; Gade CL; Singh HS; Bergman G; Wong SC; Feldman DN
    J Invasive Cardiol; 2015 Nov; 27(11):490-6. PubMed ID: 25999136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Alprostadil on the Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of 36 Randomized Controlled Trials.
    Xie J; Jiang M; Lin Y; Deng H; Li L
    Angiology; 2019 Aug; 70(7):594-612. PubMed ID: 30669852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteinuria and Reduced Estimated Glomerular Filtration Rate Are Independent Risk Factors for Contrast-Induced Nephropathy After Cardiac Catheterization.
    Saito Y; Watanabe M; Aonuma K; Hirayama A; Tamaki N; Tsutsui H; Murohara T; Ogawa H; Akasaka T; Yoshimura M; Sato A; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K;
    Circ J; 2015; 79(7):1624-30. PubMed ID: 25891891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical impact of nephropathy induced by contrast medium in patients with acute myocardial infarction undergoing emergent coronary angiography].
    Jujo K; Yamaguchi J; Obayashi K; Suzuki K; Sekiguchi H; Nagashima M; Tsurumi Y; Kasanuki H
    J Cardiol; 2006 Jul; 48(1):9-16. PubMed ID: 16886495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
    Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
    Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alpha-lipoic acid for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography: the ALIVE study - a prospective randomized trial.
    Jo SH; Kim SA; Kim HS; Han SJ; Park WJ; Choi YJ
    Cardiology; 2013; 126(3):159-66. PubMed ID: 23988855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of Contrast-Induced Nephropathy After Cardiovascular Catheterization and Intervention With High-Dose Strong Statin Therapy in Japan　- The PREVENT CINC-J Study.
    Watanabe M; Aonuma K; Murohara T; Okumura Y; Morimoto T; Okada S; Nakamura S; Uemura S; Kuwahara K; Takayama T; Doi N; Nakajima T; Horii M; Ishigami K; Nomoto K; Abe D; Oiwa K; Tanaka K; Koyama T; Sato A; Ueda T; Soeda T; Saito Y;
    Circ J; 2022 Aug; 86(9):1455-1463. PubMed ID: 35466156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Remote ischemic preconditioning for prevention of contrast induced nephropathy-Insights from an Indian study.
    Valappil SP; Kunjukrishnapillai S; Viswanathan S; Koshy AG; Gupta PN; Velayudhan RV; Iype M
    Indian Heart J; 2018; 70(6):857-863. PubMed ID: 30580857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty.
    Hernández F; Mora L; García-Tejada J; Velázquez M; Gómez-Blázquez I; Bastante T; Albarrán A; Andreu J; Tascón J
    Rev Esp Cardiol; 2009 Dec; 62(12):1373-80. PubMed ID: 20038403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contribution of platelets indices in the development of contrast-induced nephropathy.
    Sahin I; Karabulut A; Avci II; Okuyan E; Biter HI; Yildiz SS; Can MM; Gungor B; Dinckal M; Serebruany V
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):246-9. PubMed ID: 24695089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures.
    Onbasili AO; Yeniceriglu Y; Agaoglu P; Karul A; Tekten T; Akar H; Discigil G
    Heart; 2007 Jun; 93(6):698-702. PubMed ID: 17065180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures.
    Feldkamp T; Luedemann M; Spehlmann ME; Freitag-Wolf S; Gaensbacher J; Schulte K; Bajrovic A; Hinzmann D; Hippe HJ; Kunzendorf U; Frey N; Luedde M
    Clin Res Cardiol; 2018 Feb; 107(2):148-157. PubMed ID: 28939956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.